Literature DB >> 7673985

Comparative spine imaging in leptomeningeal metastases.

M C Chamberlain1.   

Abstract

Sixty-one patients (34 men; 27 women) ranging in age from 1-74, median 40 years with leptomeningeal metastases (LM) as defined by either positive CSF cytology (85%) or a clinical syndrome and compatible neuroradiographic findings (15%) underwent CT-myelographic (CT-M), spine MR (S-MR) and 111Indium-DTPA CSF flow studies (FS). Each patient underwent sequential spine imaging (CT-M, S-MR and FS) over a median of 5 days. In 57% of patients, all 3 spine imaging modalities were normal. 43% of patients demonstrated abnormalities on spine imaging; 33% had abnormal FS, 34% showed abnormalities on S-MR and 33% had abnormalities by CT-M. FS were most sensitive for detecting interruption of CSF flow whereas CT-M and S-MR better demonstrated nerve root thickening (CT-M approximately S-MR), cord enlargement (CT-M > S-MR), subarachnoid nodules (S-MR > CT-M), intraparenchymal cord tumor (S-MR > CT-M) and epidural spinal cord compression (S-MR = CT-M). In conclusion, patients with LM frequently require spine imaging and the results of this study suggest both S-MR and FS provide the best radiographic assessment wherein S-MR is superior for detecting bulky disease and FS best demonstrates interruption of CSF flow.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7673985     DOI: 10.1007/bf01059954

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  17 in total

1.  Modern concepts of brain motion and cerebrospinal fluid flow.

Authors:  D A Feinberg
Journal:  Radiology       Date:  1992-12       Impact factor: 11.105

2.  Gd-DTPA-enhanced MR imaging of leptomeningeal spread of primary intracranial CNS tumor in children.

Authors:  D J Rippe; O B Boyko; H S Friedman; W J Oakes; S C Schold; G R DeLong; W J Meisler
Journal:  AJNR Am J Neuroradiol       Date:  1990 Mar-Apr       Impact factor: 3.825

3.  Metrizamide myelography in patients with small cell carcinoma of the lung suspected of meningeal carcinomatosis.

Authors:  A G Pedersen; O B Paulson; C Gyldensted
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

4.  MR of cranial and spinal meningeal carcinomatosis: comparison with CT and myelography.

Authors:  G Krol; G Sze; M Malkin; R Walker
Journal:  AJR Am J Roentgenol       Date:  1988-09       Impact factor: 3.959

5.  Infiltration of the leptomeninges by systemic cancer. A clinical and pathologic study.

Authors:  M E Olson; N L Chernik; J B Posner
Journal:  Arch Neurol       Date:  1974-02

6.  Meningeal carcinomatosis. Clinical manifestations.

Authors:  J R Little; A J Dale; H Okazaki
Journal:  Arch Neurol       Date:  1974-02

7.  Spinal cord pial metastases: MR imaging with gadopentetate dimeglumine.

Authors:  V Lim; D F Sobel; J Zyroff
Journal:  AJNR Am J Neuroradiol       Date:  1990 Sep-Oct       Impact factor: 3.825

8.  Spinal leptomeningeal infiltration by systemic cancer: myelographic features.

Authors:  K S Kim; S U Ho; P E Weinberg; C Lee
Journal:  AJR Am J Roentgenol       Date:  1982-08       Impact factor: 3.959

9.  Comparison of myelography with CT follow-up versus gadolinium MRI for subarachnoid metastatic disease in children.

Authors:  E D Kramer; S Rafto; R J Packer; R A Zimmerman
Journal:  Neurology       Date:  1991-01       Impact factor: 9.910

10.  Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients.

Authors:  W R Wasserstrom; J P Glass; J B Posner
Journal:  Cancer       Date:  1982-02-15       Impact factor: 6.860

View more
  24 in total

Review 1.  Meningeal metastases: clinical aspects and diagnosis.

Authors:  F Formaglio; A Caraceni
Journal:  Ital J Neurol Sci       Date:  1998-06

Review 2.  Systemic chemotherapy, intrathecal chemotherapy, and symptom management in the treatment of leptomeningeal metastasis.

Authors:  Stacey L Berg; Marc C Chamberlain
Journal:  Curr Oncol Rep       Date:  2003-01       Impact factor: 5.075

Review 3.  Leukemia and the nervous system.

Authors:  Marc C Chamberlain
Journal:  Curr Oncol Rep       Date:  2005-01       Impact factor: 5.075

Review 4.  Medical imaging in the diagnosis and management of cancer pain.

Authors:  Carlos Cuevas; Dean Shibata
Journal:  Curr Pain Headache Rep       Date:  2009-08

Review 5.  Myelopathy.

Authors:  D J Seidenwurm
Journal:  AJNR Am J Neuroradiol       Date:  2008-05       Impact factor: 3.825

Review 6.  Clinical relevance and current problems of neoplastic meningosis.

Authors:  P Krauseneck
Journal:  J Neurooncol       Date:  1998 Jun-Jul       Impact factor: 4.130

Review 7.  Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials.

Authors:  Marc Chamberlain; Riccardo Soffietti; Jeffrey Raizer; Roberta Rudà; Dieta Brandsma; Willem Boogerd; Sophie Taillibert; Morris D Groves; Emilie Le Rhun; Larry Junck; Martin van den Bent; Patrick Y Wen; Kurt A Jaeckle
Journal:  Neuro Oncol       Date:  2014-05-27       Impact factor: 12.300

Review 8.  Leptomeningeal metastases from solid malignancy: a review.

Authors:  Sophie Taillibert; Florence Laigle-Donadey; Catherine Chodkiewicz; Marc Sanson; Khê Hoang-Xuan; Jean-Yves Delattre
Journal:  J Neurooncol       Date:  2005-10       Impact factor: 4.130

Review 9.  Leukemic and lymphomatous meningitis: incidence, prognosis and treatment.

Authors:  Marc C Chamberlain; Craig Nolan; Lauren E Abrey
Journal:  J Neurooncol       Date:  2005-10       Impact factor: 4.130

10.  Leptomeningeal carcinomatosis as the initial manifestation of gastric adenocarcinoma: a case report.

Authors:  Jian-Wen Guo; Xiao-Tian Zhang; Xiao-Sheng Chen; Xin-Chun Zhang; Guang-Juan Zheng; Bei-Ping Zhang; Ye-Feng Cai
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.